Visby Medical secures $100m funding to expand diagnostic test portfolio
Medical diagnostic company Visby Medical has secured more than $100m in its series E financing round to expand its diagnostic test portfolio. Led by Ping An Voyager Partners,
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XMedical diagnostic company Visby Medical has secured more than $100m in its series E financing round to expand its diagnostic test portfolio. Led by Ping An Voyager Partners,
ZAP Surgical Systems, Inc. today announced an agreement with Apollo Hospitals Enterprise Ltd. to acquire two ZAP-X® Gyroscopic Radiosurgery® systems. Apollo is well regarded as one of the
DexCom has secured breakthrough device designation from the US Food and Drug Administration (FDA) for the use of its continuous glucose monitoring (CGM) system in hospitals. Designed to
Oculogica, a leader in concussion diagnostics, today announced launch of the new EyeBOX device following FDA clearance earlier this year. The latest EyeBOX is lightweight, battery-operated, and small
South Korean molecular diagnostics firm Seegene has secured CE-IVD mark approval for its Allplex SARS-CoV-2 fast MDx Assay. With the potential to deliver results within 30 minutes, the
Biotechnology company Oxford BioDynamics has introduced its checkpoint inhibitor response test (CiRT) for oncology in the US. EpiSwitch CiRT is claimed to be the first-of-its-kind clinical blood test,
Swift Medical, the global leader in digital wound care technology, is launching an innovative product that will revolutionize the future of healthcare. Today at 2pm EST / 11am
360 Health Services is proud to announce that the Company’s distribution centers will soon complete the delivery of 1 million COVID-19 home tests to the State of North
Viz.ai has secured approval from the US Food and Drug Administration (FDA) for its artificial intelligence (AI)-based algorithm to identify suspected cerebral aneurysms. The new AI-based algorithm, dubbed
Italian contract manufacturer Lincotek has wrapped up the acquisition of a majority interest in US-based Danco Medical from Danco Anodizing for an undisclosed sum. The acquisition comprised of